Refocusing IBD Patient Management: Personalized, Proactive, and Patient-Centered Care

Area of Science:

• Gastroenterology
• Immunology
• Pharmacology

Background:

• Effective medications for inflammatory bowel disease (IBD) are available but underutilized.
• Barriers to optimal IBD treatment include payer issues, patient/provider concerns about side effects, and complex initiation logistics for biologic therapies.

Purpose of the Study:

• To address the challenges in delivering timely and effective IBD treatments.
• To advocate for optimizing current therapeutic strategies for IBD management.
• To promote a personalized, proactive, and patient-centered approach to IBD care.

Main Methods:

• Review of current challenges in IBD treatment access and delivery.
• Discussion of strategies to overcome barriers to biologic therapy initiation.
• Emphasis on early and appropriate use of existing IBD medications.

Main Results:

• Current IBD medications can effectively heal the bowel and prevent complications when used appropriately and early.
• Identifying specific patient groups who benefit from early intensive therapy is key.
• A shift towards personalized, proactive, and patient-centered care models can improve IBD management.

Conclusions:

• Optimizing the use of existing IBD therapies is essential for improving patient outcomes.
• A personalized, proactive, and patient-centered approach is recommended for enhanced IBD care delivery.
• Addressing access barriers and patient concerns can facilitate more effective IBD treatment.